Free Trial

Seilern Investment Management Ltd Sells 3,945 Shares of Mettler-Toledo International, Inc. $MTD

Mettler-Toledo International logo with Medical background

Key Points

  • Seilern Investment Management Ltd has reduced its position in Mettler-Toledo International by 5.8%, holding 64,288 shares valued at approximately $75.52 million, making it the firm's 11th largest holding.
  • Mettler-Toledo reported a quarterly earnings per share (EPS) of $10.09, exceeding analysts' expectations of $9.58, with a revenue of $983.22 million for the quarter.
  • Hedge funds and institutional investors own 95.07% of Mettler-Toledo International, indicating significant interest and investment in the company.
  • Five stocks to consider instead of Mettler-Toledo International.

Seilern Investment Management Ltd reduced its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,288 shares of the medical instruments supplier's stock after selling 3,945 shares during the quarter. Mettler-Toledo International accounts for about 5.0% of Seilern Investment Management Ltd's holdings, making the stock its 11th biggest position. Seilern Investment Management Ltd owned approximately 0.31% of Mettler-Toledo International worth $75,520,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International in the 1st quarter valued at $41,000. Zions Bancorporation National Association UT bought a new stake in Mettler-Toledo International during the 1st quarter valued at about $43,000. Golden State Wealth Management LLC boosted its holdings in shares of Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after buying an additional 35 shares during the last quarter. Menard Financial Group LLC purchased a new position in Mettler-Toledo International during the fourth quarter valued at approximately $67,000. Finally, Blue Trust Inc. raised its position in shares of Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Citigroup boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Barclays initiated coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Evercore ISI dropped their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Finally, Robert W. Baird raised their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

Read Our Latest Analysis on MTD

Mettler-Toledo International Price Performance

Shares of MTD traded down $14.53 during trading hours on Friday, hitting $1,272.58. The stock had a trading volume of 44,223 shares, compared to its average volume of 167,985. The stock has a fifty day moving average price of $1,263.93 and a 200 day moving average price of $1,186.15. The firm has a market capitalization of $26.22 billion, a PE ratio of 32.27, a PEG ratio of 3.82 and a beta of 1.37. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business earned $9.65 earnings per share. Mettler-Toledo International's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company's stock, valued at $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Articles

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.